Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno-2 study;Intensiveret multifaktoriel intervention hos patienter med type 2-diabetes mellitus og mikroalbuminuri: Steno-2-studiet

Ugeskrift for Laeger

Volumn 161, Issue 30, 1999, Pages 4277-4285

  Gœde, Peter H ^a   Jepsen, Pernille Vedel ^a   Parving, Hans Henrik ^a   Pedersen, Oluf Borbye ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALBUMINURIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; URINE;

AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 0033606662     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Parving HH, Østerby R, Anderson PW, Hsueh WA. Diabetic nephropathy. I: Brenner BM, ed. The Kidney. 5th ed. Philadelphia: Saunders, 1996: 1864-92.
2. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-60.
3. Call MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995; 44: 1303-9.
4. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishnar M. Long-term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-81.
5. Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T. Steno Study Group. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985; 34 (suppl 3): 74-9.
6. Dansk Selskab for Intern Median. Ikke-insulinkrævende diabetes mellitus. Herlev: Dansk Selskab for Intern Median, 1988.
7. Faber O, Binder C. C-peptide response to glucagon: a test for residual b-cell function in diabetes mellitus. Diabetes 1977; 26: 605-10.
8. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjølie AK, The EURODIAB IDDM Complications Study Group. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 1995; 38: 437-44.
9. Bloom S, Till S, Sönksen P, Smith S. Use of a biothesiomeler to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. Br Med J 1984; 288: 1793-5.
10. Masaoka S, Levi-Ran A, Hill LR, Vakil G, Hon EHG. Heart rate variability in diabetes: relationship to age and duration of the disease. Diabetes Care 1985; 8: 64-8.
11. Hilsted J. Pathophysiology in diabetic autonomic neuropathy: Cardiovascular, hormonal, and metabolic studies. Diabetes 1982; 31: 730-7.
12. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies: a classification system. Circulation 1960; 21: 1160-75.
13. Nielsen PE, Bell G, Lassen NA. The measurement of digital systolic blood pressure by strain gauge technique. Scand J Clin Lab Invest 1972; 29: 371-9.
14. The Diabetes Control and Complications That Research Group. The effect of intensive treatment of diabetes on the development and progression on long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
15. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 1993; 341: 1306-9.
16. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
17. The Microalbuminuria Captopril Study Group. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 1996; 39: 587-93.
18. Chaturvedi N, Sjølie AK, Stephenson JM, Abrahamian N, Keipes M, Castellarin A et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998; 351: 28-31.
19. UKPDS Group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes : UKPDS 38. BMJ 1998; 317: 703-13.
20. Feldt-Rasmussen B, Mathiesen ER, Lauritzen T, Deckert T Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991; 34: 164-70.